More about

Cedars Sinai

News
March 17, 2020
3 min read
Save

‘Spectrum of risk’ exists for papillary thyroid carcinoma

‘Spectrum of risk’ exists for papillary thyroid carcinoma

Aggressive papillary thyroid carcinoma variants appeared associated with a wide range of survival outcomes, suggesting greater emphasis should be placed on tailored treatment approaches for patients with histologically and prognostically distinct subtypes, according to study results published in JAMA Oncology.

News
March 02, 2020
4 min read
Save

Patient-reported outcomes could help guide selection of treatment for localized prostate cancer

Patient-reported outcomes could help guide selection of treatment for localized prostate cancer

Patient-reported adverse effect profiles 5 years after contemporary treatment for localized prostate cancer could help inform treatment choices for this patient population, according to study results published in JAMA.

News
February 26, 2020
3 min read
Save

FDA committee votes against approval of Tookad for localized prostate cancer

FDA committee votes against approval of Tookad for localized prostate cancer

An FDA advisory committee today voted 2-13 against recommending approval of padeliporfin di-potassium, a minimally invasive treatment for localized prostate cancer.

News
February 18, 2020
12 min read
Save

New treatments offer ‘glimmers of optimism,’ possible cure for Cushing’s disease

New treatments offer ‘glimmers of optimism,’ possible cure for Cushing’s disease

More than a century has passed since neurosurgeon and pathologist Harvey Cushing described the disease that would eventually bear his name, but only recently have several key discoveries offered patients with the condition real hope for a cure.

News
January 18, 2020
2 min read
Save

Teprotumumab significantly improves proptosis in thyroid eye disease

Teprotumumab significantly improves proptosis in thyroid eye disease

KOLOA, Hawaii — Patients with thyroid eye disease treated with teprotumumab demonstrated a significant reduction in proptosis compared with those treated with placebo, according to phase 3 results from the OPTIC trial.

News
October 23, 2019
4 min read
Save

Medical Management of IBS is Improving With Time

Medical Management of IBS is Improving With Time

In my clinic, it still feels like we get countless referrals for irritable bowel syndrome.

News
September 28, 2019
1 min read
Save

Department of Defense awards $10 million to Cedars-Sinai for pancreatic disease research

A research team led by physician-scientists from Cedars-Sinai was awarded $10 million from the Department of Defense to study risk factors and behaviors that contribute to pancreatic diseases, according to a press release.

News
September 18, 2019
14 min read
Save

Out for Blood: Biomarkers Paving the Road to Personalized Medicine for Rheumatic Diseases

Out for Blood: Biomarkers Paving the Road to Personalized Medicine for Rheumatic Diseases

There are endless idioms about blood. It is thicker than water, but one cannot get it from a stone. Truman Capote wrote about the cold version, rock band Foreigner sang about the hot version. When it comes to rheumatic diseases, researchers are out for blood — blood-based biomarkers, that is.

News
July 18, 2019
2 min read
Save

Cancer may be associated with broken heart syndrome

Cancer may be associated with broken heart syndrome

Patients with cancer had an increased risk for takotsubo syndrome, also known as broken heart syndrome, according to a study published in the Journal of the American Heart Association.

News
July 10, 2019
4 min read
Save

Nivolumab shows limited activity in untreated brain metastases from renal cell carcinoma

Nivolumab demonstrated limited activity among patients with untreated brain metastases from clear cell renal cell carcinoma who experienced progression after vascular endothelial growth factor receptor-directed therapy, according to results of a phase 2 study published in Journal of Clinical Oncology.

View more